Artificial intelligence-driven patient monitoring for adverse event detection in clinical trials

Simple item page
dc.contributor.authorVampana, S. B.en_US
dc.contributor.authorJayanthi, E. S. S.en_US
dc.contributor.authorMary, D. A.en_US
dc.contributor.authorSriniketh, C.en_US
dc.date.accessioned2024-09-24T06:14:02Z
dc.date.available2024-09-24T06:14:02Z
dc.date.issued2024-08
dc.description.abstractArtificial intelligence (AI) keeps an eye on people in clinical studies to find out when bad things happen. This is a big way that AI is changing healthcare. It goes into a lot of detail about how AI has changed this field and stresses how important it is to use complicated formulas, always keep an eye on things, and follow the rules. These days, we have tools like deep learning frameworks, controlled and unsupervised learning models, and others that help us find bad things faster and more accurately. Tracking in real time is possible with early warning systems and constant data analysis. It helps make sure the experiment is done right and puts the safety of the people being tested first. AI-driven tracking systems can only work in an honest and reliable way if they follow the rules set by regulatory bodies such as the FDA and the EMA. The fact that AI has the ability to change the way medical research is done today, with benefits like making it faster and more accurate, makes its problems even more important. The report comes to the conclusion that more research, better teamwork, and a wider use of AI technologies are needed to make it more reliable to find bad events in clinical studies over time.en_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Pulla Reddy Institute of Pharmacy, Hyderabad, Telangana, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Pulla Reddy Institute of Pharmacy, Hyderabad, Telangana, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Pulla Reddy Institute of Pharmacy, Hyderabad, Telangana, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Pulla Reddy Institute of Pharmacy, Hyderabad, Telangana, Indiaen_US
dc.identifier.citationVampana S. B., Jayanthi E. S. S., Mary D. A., Sriniketh C.. Artificial intelligence-driven patient monitoring for adverse event detection in clinical trials. International Journal of Basic & Clinical Pharmacology. 2024 Jul; 13(4): 543-550en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/226773
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber4en_US
dc.relation.volume13en_US
dc.source.urihttps://doi.org/10.18203/2319-2003.ijbcp20241657en_US
dc.subjectArtificial intelligenceen_US
dc.subjectPatient monitoringen_US
dc.subjectAdverse event detectionen_US
dc.subjectAdvanced algorithmsen_US
dc.subjectReal-time surveillanceen_US
dc.subjectRegulatory complianceen_US
dc.subjectHealthcare innovationen_US
dc.titleArtificial intelligence-driven patient monitoring for adverse event detection in clinical trialsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijbcp2024v13n4p543.pdf
Size:
262.1 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology